No Picture
News

?Sorrento to Present New Data on Advanced Immunotherapies at Multiple Upcoming Scientific Conferences

SAN DIEGO, Nov. 06, 2019 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”), announced today that Dr. Henry Ji, Chairman and CEO, and members of Sorrento?s research team will participate in upcoming industry conferences in the… […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Synthorx Reports Third Quarter Financial Results

SAN DIEGO, Nov. 05, 2019 (GLOBE NEWSWIRE) — Synthorx, Inc. (Nasdaq: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, today reported financial results and provided a business update … […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Synthorx Reports Third Quarter Financial Results

SAN DIEGO, Nov. 05, 2019 (GLOBE NEWSWIRE) — Synthorx, Inc. (Nasdaq: THOR), a clinical-stage biotechnology company developing optimized therapeutics for cancer and autoimmune disorders, today reported financial results and provided a business update … […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Ligand Reports Third Quarter 2019 Financial Results

SAN DIEGO–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three and nine months ended September 30, 2019 and provided an operating forecast and program updates. Ligand management will host a… […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Oncternal Therapeutics Announces Interim Clinical Data on TK216 in Ewing Sarcoma to Be Presented at the CTOS 2019 Annual Meeting

SAN DIEGO–(BUSINESS WIRE)–Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that interim data on TK216 ? an investigational targeted small m… […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

As CRISPR horizons cloud, a startup focuses on the next big thing with powerhouse potential ? the RNA editing platform

Over the last few years, as CRISPR/Cas9 gene editing tech became the AK47 of academic labs ? a handy, powerful weapon that could be pointed at multiple targets ? there has been a growing chorus of skeptics pointing to what they see as severe limitation… […]

No Picture
News

Biogen to Host Investor Webcasts from Clinical Trials on Alzheimer?s Disease (CTAD) Congress on December 5, 2019

CAMBRIDGE, Mass., Nov. 04, 2019 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) today announced it will host live webcasts of its oral presentation and a Q&A session related to its Alzheimer?s disease investigational therapy, aducanumab, at the upcomin… […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

ACADIA Pharmaceuticals Appoints Ponni Subbiah, M.D., M.P.H., as Senior Vice President, Global Head of Medical Affairs and Chief Medical Officer

SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) today announced the appointment of Ponni Subbiah, M.D., M.P.H., as Senior Vice President, Global Head of Medical Affairs and Chief Medical Officer. Dr. Subbiah will report to Serge … […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks